Polarityte Inc 's

Name: Polarityte Inc Comparisons to its Competitors and Market Share - CSIMarket
Creator: CSIMarket.com
License: https://csimarket.com/help/terms-of-use/

Competitiveness

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PTE Sales vs. its Competitors Q4 2023

Select the Relationship:

Competition ▼

Select the Category:

Comparison ▼

Competition ▼

Basic Report▼

Revenue Growth Comparisons

Net Income Comparison

Polarityte Inc , faster than the decline experienced by the competitors recorded a net loss, as well as most of its competitors.

<< PTE Stock Performance Comparisons

<< See the full list of PTE competitors

*Market share is calculated based on total revenue.

PTE's Stock Performance relative to its Competitors

Publicly Traded Peers of Polarityte Inc

Fibrobiologics Inc
Share Performance

+166.75%

30 Days

Fibrobiologics Inc

Profile

FibroBiologics develops fibroblast-based therapies targeting chronic diseases and applications related to longevity.

More about Fibrobiologics Inc 's Market Share

Market Cap.	Revenues TTM	Net Income TTM
$ 13.235 mill.	$ - mill.	$ -18.139 mill.

Sources: Polarityte Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, August 30, 2026 2:32 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Polarityte Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.